<DOC>
	<DOCNO>NCT02508259</DOCNO>
	<brief_summary>This study design test safety efficacy single , intravenous dose suramin autism spectrum disorder ( ASD ) .</brief_summary>
	<brief_title>University California , San Diego ( UCSD ) Suramin Treatment Trial Autism</brief_title>
	<detailed_description>This study design test new theory origin treatment ASD . In theory , ASD cause gene environment interact produce persistent cell danger response ( CDR ; Naviaux RK , 2014 ) interfere alters normal child brain development . Gut microbiome immune system also affect . In theory , pathological persistence cell danger response traceable mitochondrion , maintain purinergic signaling mediate release extracellular nucleotide like adenosine triphosphate ( ATP ) , adenosine diphosphate ( ADP ) , uridine triphosphate ( UTP ) , uridine diphosphate ( UDP ) . Suramin inhibit excess purinergic signal act competitive inhibitor nucleotide signal ionotropic purinergic ( P2X ) receptor , G-protein couple , metabotropic purinergic ( P2Y ) receptor . Suramin find correct symptom , metabolism , brain synaptic abnormality two classical genetic environmental mouse model autism ( Naviaux JC , et al . 2015 ; Naviaux JC , et al . 2014 ; Naviaux RK , et al . 2013 ) . This study test safety efficacy single dose suramin child ASD . While anticipated single dose produce benefit week , successful , study may lead development new safer drug autism treatment .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Suramin</mesh_term>
	<criteria>Autism diagnostic observation schedule ( ADOS ) score ≥ 7 Diagnosis autism spectrum disorder Diagnostic Statistical Manual , 5th edition ( DSMV ) Stable treatment diet regimen ≥ 2 month Resident San Diego region Any prescription medication Hospitalization within previous 2 month Active medical problem seizure , heart , liver , kidney , adrenal disease Planning start new drug , diet , behavioral intervention study Weight 5th percentile age Unable tolerate venipuncture , urine collection , indwell intravenous catheter 34 hour Plasma creatinine ≥ 1.4 mg/dl Liver function alanine amino transferase ( ALT ) aspartate amino transferase ( AST ) ≥ 1.5fold upper limit normal Known intolerance suramin antipurinergic drug Unable perform cooperate study requirement</criteria>
	<gender>Male</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>mitochondrion</keyword>
	<keyword>purinergic signal</keyword>
	<keyword>cell danger response</keyword>
</DOC>